Rollout of the Novavax COVID-19 vaccine is expected to begin next month.

The Therapeutic Goods Administration (TGA) has given the Novavax vaccine the green light, but the final decision is now in the hands of the Australian Technical Advisory Group on Immunisation (ATAGI).

ATAGI will determine who can access the vaccine.

Australia has secured 51 million doses of Novavax.

Infectious diseases and immunology expert at Griffith University, Professor Nigel McMillan said he has had a lot of people asking him when it would be available.

He said it was developed in a more traditional way.

“The mRNA technology, its’s really the first time we have used it in large scale clinical trials, it’s just a set of instructions to make the protein in your cells,” he told Scott Emerson.

“With Novavax, it’s already made the protein, the protein is in the injection so it just gets injected into your arm, so your immune cells come and have a look at it, and they start making a reaction.”

He also weighed in on whether Novavax could be given as a booster shot.

Press PLAY below to hear more of his explanation on Novavax 

Image: Getty iStock